mitoxantrone has been researched along with Fallopian Tube Neoplasms in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Fallopian Tube Neoplasms: Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kehoe, SM | 1 |
| Williams, NL | 1 |
| Yakubu, R | 1 |
| Levine, DA | 1 |
| Chi, DS | 1 |
| Sabbatini, PJ | 1 |
| Aghajanian, CA | 1 |
| Barakat, RR | 1 |
| Abu-Rustum, NR | 1 |
1 other study available for mitoxantrone and Fallopian Tube Neoplasms
| Article | Year |
|---|---|
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Fallo | 2009 |